11 results
dm2 summary inhibitors agonists diagnosis dosing dpp4 glp1 sglt2 signs symptoms adrenal cah congenital deficiency glftap hydroxylase hyperplasia macroadenoma management
Clinical Effects of Large and Small Pituitary Tumours Local complications - Headache, Visual field defect, Disconnection hyperprolactinaemia,
Clinical Effects ... Large and Small Pituitary ... , Visual field defect ... #Tumors #Signs ... Symptoms #Diagnosis #Endocrinology
Pituitary Mass Effects - Pathogenesis and Clinical Findings • Pituitary turnors are almost always a benign
Pituitary Mass Effects ... Pituitary adenomas ... Signs / Symptoms ... Hyperprolactinemia • Diabetes ... #SideEffects #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... CKD Common Side Effects ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Congenital Adrenal Hyperplasia - 21-Hydroxylase Deficiency - Signs and Symptoms • Brain: Androgenization effects, Glucocorticoid effects,
Hydroxylase Deficiency - Signs ... Glucocorticoid effects ... • Hypothalamic–Pituitary ... Hydroxylase #Deficiency #Signs ... Symptoms #diagnosis #endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... ) Common Side Effects ... • Euglycemic diabetic ... #Summary #DM2 #diabetes ... #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Side effects include ... SGLT2 #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes ... #Endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... disease Common Side Effects ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Toxicities: • Gl side effects ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... failure Common Side Effects ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... Common side effects ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
No results found for "Defects+signs collateral pharmacology endocrinology pituitary diabetes"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Defects+signs #collateral #pharmacology #endocrinology #pituitary #diabetes